118 related articles for article (PubMed ID: 24486183)
41. No association of two common SNPs at position -1727 A/T, -50 C/T of GSK-3 beta polymorphisms with schizophrenia and bipolar disorder of Korean population.
Lee KY; Ahn YM; Joo EJ; Jeong SH; Chang JS; Kim SC; Kim YS
Neurosci Lett; 2006 Mar; 395(2):175-8. PubMed ID: 16289845
[TBL] [Abstract][Full Text] [Related]
42. [Association between GSK3β polymorphisms and the smoking habits in young Japanese].
Nagahori K; Iwahashi K; Narita S; Numajiri M; Yoshihara E; Nishizawa D; Ikeda K; Ishigooka J
Nihon Shinkei Seishin Yakurigaku Zasshi; 2015 Jun; 35(3):73-7. PubMed ID: 26281299
[TBL] [Abstract][Full Text] [Related]
43. Case-control association study of GRIA1, GRIA2 and GRIA4 polymorphisms in bipolar disorder.
Chiesa A; Crisafulli C; Porcelli S; Balzarro B; Han C; Patkar AA; Lee SJ; Park MH; Pae CU; Serretti A
Int J Psychiatry Clin Pract; 2012 Mar; 16(1):18-26. PubMed ID: 22122651
[TBL] [Abstract][Full Text] [Related]
44. Genetic variants of GSK3B are associated with biomarkers for Alzheimer's disease and cognitive function.
Kettunen P; Larsson S; Holmgren S; Olsson S; Minthon L; Zetterberg H; Blennow K; Nilsson S; Sjölander A
J Alzheimers Dis; 2015; 44(4):1313-22. PubMed ID: 25420549
[TBL] [Abstract][Full Text] [Related]
45. Common Polymorphisms in the GSK3β Gene May Contribute to the Pathogenesis of Alzheimer Disease: A Meta-Analysis.
Lin Q; Cao YP; Gao J
J Geriatr Psychiatry Neurol; 2015 Jun; 28(2):83-93. PubMed ID: 25351705
[TBL] [Abstract][Full Text] [Related]
46. The involvement of GSK3beta in bipolar disorder: integrating evidence from multiple types of genetic studies.
Luykx JJ; Boks MP; Terwindt AP; Bakker S; Kahn RS; Ophoff RA
Eur Neuropsychopharmacol; 2010 Jun; 20(6):357-68. PubMed ID: 20226637
[TBL] [Abstract][Full Text] [Related]
47. Lack of association of three GRIN2B polymorphisms with bipolar disorder.
Szczepankiewicz A; Skibinska M; Rybakowski J; Leszczynska-Rodziewicz A; Tomaszewska M; Twarowska-Hauser J
World J Biol Psychiatry; 2009; 10(4 Pt 2):469-73. PubMed ID: 19005876
[TBL] [Abstract][Full Text] [Related]
48. Glycogen synthase kinase 3 beta gene structural variants as possible risk factors of bipolar depression.
Ronai Z; Kovacs-Nagy R; Szantai E; Elek Z; Sasvari-Szekely M; Faludi G; Benkovits J; Rethelyi JM; Szekely A
Am J Med Genet B Neuropsychiatr Genet; 2014 Apr; 165B(3):217-22. PubMed ID: 24677591
[TBL] [Abstract][Full Text] [Related]
49. Trait impulsivity as an endophenotype for bipolar I disorder.
Lombardo LE; Bearden CE; Barrett J; Brumbaugh MS; Pittman B; Frangou S; Glahn DC
Bipolar Disord; 2012 Aug; 14(5):565-70. PubMed ID: 22805501
[TBL] [Abstract][Full Text] [Related]
50. Association between serotonin 4 receptor gene polymorphisms and bipolar disorder in Japanese case-control samples and the NIMH Genetics Initiative Bipolar Pedigrees.
Ohtsuki T; Ishiguro H; Detera-Wadleigh SD; Toyota T; Shimizu H; Yamada K; Yoshitsugu K; Hattori E; Yoshikawa T; Arinami T
Mol Psychiatry; 2002; 7(9):954-61. PubMed ID: 12399948
[TBL] [Abstract][Full Text] [Related]
51. The association study of three FYN polymorphisms with prophylactic lithium response in bipolar patients.
Szczepankiewicz A; Skibinska M; Suwalska A; Hauser J; Rybakowski JK
Hum Psychopharmacol; 2009 Jun; 24(4):287-91. PubMed ID: 19330793
[TBL] [Abstract][Full Text] [Related]
52. Pre-attentive information processing and impulsivity in bipolar disorder.
Swann AC; Lijffijt M; Lane SD; Steinberg JL; Acas MD; Cox B; Moeller FG
J Psychiatr Res; 2013 Dec; 47(12):1917-24. PubMed ID: 24054520
[TBL] [Abstract][Full Text] [Related]
53. [Evaluation of the Association between Lithium Treatment and GSK3β Polymorphism in Bipolar Disorder Patients].
Altınbaş K; Yeşilbaş D; İnce B; Cansız A; Sılan F; Özdemir Ö; Gülöksüz S
Turk Psikiyatri Derg; 2018; 29(2):73-78. PubMed ID: 30215834
[TBL] [Abstract][Full Text] [Related]
54. Impulsivity and functional impairment in bipolar disorder.
Jiménez E; Arias B; Castellví P; Goikolea JM; Rosa AR; Fañanás L; Vieta E; Benabarre A
J Affect Disord; 2012 Feb; 136(3):491-7. PubMed ID: 22129768
[TBL] [Abstract][Full Text] [Related]
55. Screening for bipolar disorder in a Spanish sample of outpatients with current major depressive episode.
Tafalla M; Sanchez-Moreno J; Diez T; Vieta E
J Affect Disord; 2009 Apr; 114(1-3):299-304. PubMed ID: 18701169
[TBL] [Abstract][Full Text] [Related]
56. GSK-3β polymorphism discriminates bipolar disorder and schizophrenia: a systematic meta-analysis.
Tang H; Shen N; Jin H; Liu D; Miao X; Zhu LQ
Mol Neurobiol; 2013 Dec; 48(3):404-11. PubMed ID: 23440732
[TBL] [Abstract][Full Text] [Related]
57. The gender-specific association of rs334558 in GSK3β with major depressive disorder.
Liu S; Wang L; Sun N; Yang C; Liu Z; Li X; Cao X; Xu Y; Zhang K
Medicine (Baltimore); 2017 Jan; 96(3):e5928. PubMed ID: 28099358
[TBL] [Abstract][Full Text] [Related]
58. GSK3B polymorphisms alter transcription and splicing in Parkinson's disease.
Kwok JB; Hallupp M; Loy CT; Chan DK; Woo J; Mellick GD; Buchanan DD; Silburn PA; Halliday GM; Schofield PR
Ann Neurol; 2005 Dec; 58(6):829-39. PubMed ID: 16315267
[TBL] [Abstract][Full Text] [Related]
59. GSK3β polymorphisms, MAPT H1 haplotype and Parkinson's disease in a Greek cohort.
Kalinderi K; Fidani L; Katsarou Z; Clarimón J; Bostantjopoulou S; Kotsis A
Neurobiol Aging; 2011 Mar; 32(3):546.e1-5. PubMed ID: 19573950
[TBL] [Abstract][Full Text] [Related]
60. Glycogen synthase kinase 3 involvement in the excessive proinflammatory response to LPS in patients with decompensated cirrhosis.
Coant N; Simon-Rudler M; Gustot T; Fasseu M; Gandoura S; Ragot K; Abdel-Razek W; Thabut D; Lettéron P; Ogier-Denis E; Ouziel R; Devière J; Lizard G; Tellier Z; Lebrec D; Moreau R
J Hepatol; 2011 Oct; 55(4):784-93. PubMed ID: 21334395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
